Effect of hepatic and renal dysfunction on disposition of Bupropion in rats Juzar S. KakaKhalil I. Al-KhamisMusbah O. M. Tanira Original Papers Pages: 149 - 153
Pharmacodynamics and pharmacokinetics of furosemide-retard and furosemide-retard/triamterene V. HeimsothD. LoewO. Schuster Original Papers Pages: 161 - 164
Metabolism of n-hexyl-homologues of delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in the mouse N. K. BrownD. J. Harvey Original Papers Pages: 165 - 176
N1-Glucosides as urinary metabolites of sulphadimidine, sulphamerazine and sulphamethoxazole B. AhmadJ. W. Powell Original Papers Pages: 177 - 183
Pharmacokinetics of the dopamine partial agonist, terguride, in the rat and rhesus monkey W. KrauseM. Hümpel Original Papers Pages: 185 - 194
Pharmacokinetics of pyrazinamide in plasma and CSF of rabbits following intravenous and oral administration K. ChanC. L. Wong Original Papers Pages: 195 - 199
The effects of once-daily dosing with ranitidine and cimetidine on theophylline pharmacokinetics J. McEwenM. E. T. McMurdoT. A. Moreland Original Papers Pages: 201 - 205
The antipyrine breath test in the rat: a pharmacokinetic model Graham F. LockwoodRichard J. ChenerySarah J. Norman Original Papers Pages: 207 - 214
Pharmacokinetics of pirazolac, a new anti-inflammatory drug, in human volunteers III. Steady state plasma levels U. TäuberR. -O. BeiersdorffH. Matthes Original Papers Pages: 215 - 220